Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Propanc Biopharma ( (PPCB) ) has issued an announcement.
On July 18, 2025, Propanc Biopharma, Inc. issued a Promissory Note worth $82,500 to an accredited investor for a purchase price of $75,000, with the proceeds intended for general working capital. The Note, due by September 15, 2025, bears a 10% annual interest rate, with specific repayment terms depending on the repayment date, potentially impacting the company’s financial strategy and investor relations.
More about Propanc Biopharma
Propanc Biopharma, Inc. is a company operating in the biopharmaceutical industry, focusing on the development of cancer treatments.
Average Trading Volume: 2,957
Technical Sentiment Signal: Strong Sell
Current Market Cap: $52.25M
For a thorough assessment of PPCB stock, go to TipRanks’ Stock Analysis page.